Tibial Delayed Healing

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Tibial Delayed Healing trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06658379

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

In approx. 10-15% of all fracture patients, there is a prolonged healing time or even a complete absence of fracture healing (non-union). As a result, these pat…

Germany640 participantsStarted 2016-12

Treatment: CD8+TEMRA

All recent trials (3 shown)

CompletedPhase 2

NCT01842477

Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing

Bone grafting is widely used in hospitals to repair injured, aged or diseased skeletal tissue. In Europe, about one million patients encounter a surgical bone r…

France, Germany +2 more30 participantsStarted 2013-05

Treatment: Implantation of bone substitute plus autologous cultured mesenchymal cells

TerminatedPhase 3

NCT01016067

Tibial Delayed Healing Pivotal Clinical Trial

Evaluate the INFUSE/MASTERGRAFT™ Delayed Healing Device as an alternative/replacement to autograft in the treatment of tibial delayed healing.

United States23 participantsStarted 2010-11

Treatment: INFUSE/MASTERGRAFT, Autograft bone